| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,681,482 | 3,885,164 | 3,666,307 | 3,802,404 | | Cost of Revenue | 2,721,207 | 2,413,540 | 2,384,992 | 2,765,513 | | | Gross Profit | 1,960,275 | 1,471,624 | 1,281,315 | 1,036,891 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 212,882 | 208,089 | 199,880 | 194,388 | | Non Recurring | (202,000) |
-
| 202,000 |
-
| | Others | 332,117 | 377,341 | 389,758 | 373,356 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,415,276 | 886,194 | 489,677 | 469,147 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (148,780) | 109,093 | 3,499 | (58,352) | | Earnings Before Interest And Taxes | 1,468,462 | 995,967 | 492,200 | 464,250 | | Interest Expense | 226,345 | 275,442 | 183,115 | 200,877 | | Income Before Tax | 1,242,117 | 720,525 | 309,085 | 263,373 | | Income Tax Expense | 435,947 | 225,717 | 167,169 | 77,395 | | Minority Interest |
-
|
-
|
-
| 48,584 | | | | Net Income From Continuing Ops | 788,656 | 494,808 | 141,916 | 185,978 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 806,170 | 494,808 | 141,916 | 185,978 | | Preferred Stock And Other Adjustments | (16,195) | (16,195) | (16,195) |
-
| | | Net Income Applicable To Common Shares | $789,975 | $478,613 | $125,721 | $185,978 |
|
0.03% Nasdaq 0.00%
Income Statement
